Modulation of IL‐4‐induced human IgE production in vitro by IFN‐γ and IL‐5: The role of soluble CD23 (s‐CD23)
- 1 March 1989
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 39 (3) , 253-264
- https://doi.org/10.1002/jcb.240390305
Abstract
IL‐4 specifically induced IgE production by peripheral blood lymphocytes or by tonsil or spleen cells from healthy donors. IL‐4‐induced IgE synthesis was dependent on CD4+ T cells and monocytes and was blocked by IFN‐γ, IFN‐α, and prostaglandin E‐2 (PGE‐2). These substances also inhibited IL‐4‐induced CD23 expression and subsequent release of soluble CD23 (s‐CD23). In addition, IgE production was blocked by F(ab′)2 fragments of an mAb against CD23. In contrast, IL‐5 enhanced IL‐4‐induced IgE production, provided IL‐4 was added at nonsaturating concentrations. This increase in IgE production correlated quantitatively with an enhanced release of s‐CD23. Collectively, these results indicate that there is a correlation between s‐CD23 release and IgE production. However, s‐CD23 fractionated from supernatants of the lymphoblastoid cell line RPMI‐8866 was ineffective in inducing IgE production in the absence of IL‐4, but acted synergistically with suboptimal concentrations of IL‐4. In addition, it is demonstrated that alloreactive T‐cell clones produced varying concentrations of IL‐4, IL‐2, or IFN‐γ upon stimulation. Only supernatants of 2/4 of these T‐cell clones induced a low degree of IgE synthesis, but in the presence of anti‐IFN‐γ antibodies, all four supernatants induced a strong induction of IgE production. This IgE synthesis was blocked specifically by anti‐IL‐4 antibodies, indicating that IL‐4 is the sole inducer of IgE synthesis. Our findings demonstrate that IL‐4‐induced IgE production involves complex interactions of T cells, B cells, and monocytes and is positively modulated by IL‐5 and s‐CD23 but down‐regulated by IFN‐γ, IFN‐α, and PGE‐2, respectively.Keywords
This publication has 28 references indexed in Scilit:
- IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.Proceedings of the National Academy of Sciences, 1988
- Interleukin 5 enhances interleukin 4‐induced IgE production by normal human B cells. The role of soluble CD23 antigenEuropean Journal of Immunology, 1988
- Human tonsillar IgE biosynthesis in vitro *1, *2II. Analysis of T cell regulation with monoclonal antibodiesJournal of Allergy and Clinical Immunology, 1988
- Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE‐binding factor analogous to that spontaneously released by lymphoblastoid B cell linesEuropean Journal of Immunology, 1988
- Differential regulation of IgG1 and IgE synthesis by interleukin 4.The Journal of Experimental Medicine, 1988
- Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.The Journal of Experimental Medicine, 1987
- Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.Proceedings of the National Academy of Sciences, 1986
- Molecular structure of human lymphocyte receptor for immunoglobulin ECell, 1986
- Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.The Journal of Immunology, 1986
- Induction of IgE synthesis in normal human B cells. Sequential requirements for activation by an alloreactive T cell clone and IgE-potentiating factors.The Journal of Experimental Medicine, 1986